Updated HCV guidelines released on February 24, 2016 by AASLD and IDSA

The following sections have been updated :

Initial Treatment of HCV infection : http://www.hcvguidelines.org/printpdf/71

Retreatment of Persons in Whom Prior Therapy has Failed : http://www.hcvguidelines.org/printpdf/73

Unique Patient Populations: Patients with Renal Impairment : http://www.hcvguidelines.org/printpdf/159

Unique Patient Populations: Patients with decompensated cirrhosis : http://www.hcvguidelines.org/printpdf/161

Unique Patient Populations: Patients who Develop Recurrent HCV Infection Post-Liver Transplantation : http://www.hcvguidelines.org/printpdf/160

HCV Testing and Linkage to Care : http://www.hcvguidelines.org/printpdf/12

Monitoring Patients who are Starting Hepatitis C Treatment, are on Treatment, or have Completed Therapy : http://www.hcvguidelines.org/printpdf/92

This version of the Guidance has been updated to reflect several important developments, including the recent approval of elbasvir/grazoprevir, together with new information regarding the use of testing for HCV resistance associated variants."

Pr François Raffi